Human Development Neurotoxicology describes the most recent developments in the design, execution, and interpretation of human developmental neurotoxicology studies.
Features:
- Offers strategies to incorporate developmental neurotoxicity data into the risk assessment process
- Supplies techniques to enhance and strengthen exposure and endpoint testing and correctly approach data collection and utilization
- Compares animal and human endpoint assessments
- Discusses emerging issues such as endocrine disruptors and pesticides, and the application of neuroimaging techniques in neurotoxicological studies
- Includes a survey of alternative statistical methods to derive 'points of departure' for the development of exposure standards
Contents
Environmental Chemicals
- Methylmercury
- Polychlorinated Biphenyls
- Solvents
- Pesticides
Medicinals
- Retinoids
- Chemotherapeutic Drugs
Recreational Substance Use
- Maternal Smoking During Pregnancy and ETS
- Cocaine
Exposure Assussment and Pharmacokinetic Models
- Metals
- Pesticides
- Drugs of Abuse
Endpoint Assessment
- Parallels Between Animal and Human Models of Nerobehavioral Disorders: General Considerations
- Neuropsycchological Assessment Issues and Strategies
- Role of Neuroimaging
- Childhood Exposures and Adult Disease
Data Analysis and Defining Bases of Individual Suseptibility
- The Experimentalist Perspective
- Applications of Structural Equation Modeling
- The Social-Ecological Perspective. Molecular Mechanisms
Increasing the Relevance and Utility of Data from Developmental Neurotoxicity Studies to Clincal Practice and to Risk Assessment
- Ethical Considerations
- The Political and Economic Contexts
- Clinician Perspective
- Public Health Perspective
Index